CIMG Inc. Delisted from Nasdaq, Trading Suspended; Moves to OTC Market

summarizeSummary

CIMG Inc. has been delisted from The Nasdaq Stock Market due to multiple listing rule violations, with trading suspended and the stock now quoted on the over-the-counter market.

check_boxKey Events

• Nasdaq Delisting Finalized

  On March 4, 2026, CIMG Inc. received notice that the Nasdaq Hearings Panel determined to delist its common stock due to failures to comply with multiple listing rules (5550(a)(2), 5250(c)(1), 5550(b)(1), and 5620(a)). This follows previous delisting notices, including one on February 27, 2026, for failing to timely file its Q4 2025 Form 10-Q.

• Trading Suspended and Moved to OTC

  Trading in the company's common stock was suspended at the open of trading on March 6, 2026. As of the same date, the stock may be quoted and traded in the over-the-counter market under the symbol 'CIMG'.

• Company Plans Appeal

  CIMG Inc. has 15 calendar days from the Panel's decision to request a review by the Nasdaq Listing and Hearing Review Council and currently expects to appeal the decision.

• Exacerbates Financial Distress

  This delisting compounds the company's severe financial challenges, including 'going concern' doubts and a critically low cash balance of $45,356, as revealed in its overdue 10-Q filed on March 5, 2026.

auto_awesomeAnalysis

This filing confirms the final decision by the Nasdaq Hearings Panel to delist CIMG Inc.'s common stock, following previous notices of non-compliance. Trading has already been suspended, and the stock has moved to the over-the-counter market. This is a critical negative development, significantly impacting the company's liquidity, investor confidence, and ability to raise capital. The delisting exacerbates the severe going concern doubts and critically low cash balance disclosed in the recent 10-Q filing. While the company plans to appeal, the immediate impact is a loss of Nasdaq listing status, which is a major blow to its public market standing.